Transparent Machine Learning Stocks + Digital Assets Forecasts*
If you don't make over $60 your first month, get your money back.
Become a more profitable investor with our transparent AI stock forecasts.
Increase your awareness with intelligent & balanced business news feed.
Stay on top with forecast models models trained, tested, and updated every day.
The news feed designed to reduce addiction and increase your understanding.
We will never sell, rent, or give your personal information away under any circumstance.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
The blue line is Helium's historical forecast. The black line is the actual closing price. Full transparency of past predictions. Hover over points for more information. Video Tutorial.
Future Price Cone
The future price cone means the model thinks there is a 80% chance the price will land within the bounds of the cone. A blue cone is neutral, a green cone is bullish, and a red cone is bearish.
Model Correlation
Higher (closer to 1) means a more accurate model and lower (closer to -1) means a less accurate model. This is the Spearman Correlation between model predicted percent change and actual percent change calculated over the last 150 days.
Percent Correct (up or down)
This is the percent of the time our models predicted the correct direction of the price (either up or down) over the last 150 days.
Tip:
Left click and drag charts to zoom in. Right click to zoom back out.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
Helium Summary:
Recent studies reveal significant strides in understanding and treating breast cancer.
These include the role of centrosomes in cancer pathogenesis [NCBI], links between type 2 diabetes and certain cancers [The Independent], methodologies for early detection and improved survival rates using AI [Nature], and novel pharmaceutical approaches such as pelareorep trials [baystreet.ca]. Breast cancer remains a leading cause of mortality among women globally, underpinning these research efforts [baystreet.ca][NCBI][The Independent][Nature].
April 18, 2024
Evidence
Centrosomes play a crucial role in chromosomal instability in cancer [NCBI].
AI significantly outperforms pathologists in diagnosing the origin of metastatic cancers [Nature].
Perspectives
Medical Researcher
Emphasizes the transformative potential of these findings for clinical applications, but also notes the early stages of many studies and the long road to practical implementation [NCBI][The Independent][baystreet.ca].
Pharmaceutical Industry
Focuses on the commercial prospects of new drugs and therapies, highlighting the importance of FDA approvals and market impact [NCBI][baystreet.ca].
Patient Advocacy Groups
Advocates for greater access to emerging treatments and diagnostic tools, emphasizing patient support and education [baystreet.ca][The Independent].
Q&A
How does the new AI model improve cancer diagnosis efficiency?
By accurately identifying cancer origins, reducing the need for invasive procedures, and possibly improving survival rates [Nature]. What role do centrosomes play in cancer's aggressiveness?
They are involved in chromosomal segregation; their dysfunction can lead to chromosomal instability, a hallmark of cancer [NCBI].
Sources like NCBI and academic journals [NCBI][The Independent] generally provide reliable, peer-reviewed information, though the complexity of data may limit accessibility to non-specialists.
Question these sources for commercial ties that may affect the publication of results favorable to particular drugs or therapies.
Social Media Perspectives
The emotions surrounding advancements in breast cancer research span a wide spectrum.
On one end, there's hope and triumph, as evidenced by a social media post celebrating a "1-0" victory over breast cancer.
Another social media post shares a personal, poignant plea for a successful partial mastectomy, highlighting the anxiety and hope that accompanies such procedures.
A social media post about the untimely passing of a mentor, related to breast cancer amidst systemic issues, adds a layer of somber reflection on the broader impacts of the disease.
Overall, these sentiments weave a complex tapestry of personal resilience, communal support, and the fervent desire for continued research progress.
Context
The context includes an urgent global need for effective breast cancer treatments due to rising prevalence and mortality.
Takeaway
While significant research advancements suggest improved future treatment, actual patient outcomes hinge on accessibility and continued innovation.
Potential Outcomes
Continuous improvement in breast cancer mortality rates, Probability: High, as treatment and detection technologies advance.
Increased discrepancy in treatment accessibility, Probability: Moderate, depending on healthcare policy changes and pharmaceutical pricing strategies.
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.
Ask any question about this page!
